Commentary on hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications.
Hastings
Kenneth L
KL
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA. hastingsk@cder.fda.gov
D000222:Adaptation, Physiological / Q000187:drug effects* / Q000276:immunology*; D016572:Cyclosporine / Q000276:immunology / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000276:immunology; D004358:Drug Therapy; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009626:Terminology as Topic; D015262:Xenobiotics / Q000276:immunology / Q000494:pharmacology
D015262:Xenobiotics; D016572:Cyclosporine